Table 1.
Variables | Reference range | On admission | 6 weeks after treatment |
---|---|---|---|
Serum Levels | |||
Hemoglobin (g/dL) | 12.3–15.3 | 13.1 | |
Leukocytes (per mm3) | 4,400–11,300 | 7,100 | |
Platelets (per mm3) | 150,000–450,000 | 278,000 | |
ESR (mm/h) | <20 | 21 | |
C-reactive protein (mg/L) | 0–20 | 2.81 | |
Glucose (mg/dL) | 70–99 | 85 | 88 |
Uric acid (mg/dL) | 2.6–6 | 1.28 | |
Albumin (g/dL) | 3.5–5.2 | 4.95 | |
Globulin (g/dL) | 2.5–3.5 | 3.55 | |
Calcium (mg/dL) | 8.4–10.2 | 9.2 | 8.8 |
Phosphorus (mg/dL) | 2.3–4.7 | 1.46 | 2.29 |
PTH (pg/mL) | 12–72 | 114 | |
25(OH)D (ng/mL) | 32–70 | 22.78 | |
Alkaline Phosphatase (UI/L) | 40–150 | 322 | |
Potassium (mEq/L) | 3.5–5.1 | 2.85 | 3.8 |
Sodium (mEq/L) | 136–145 | 134.5 | 136 |
Chloride (mg/dL) | 98–107 | 111.47 | 108 |
Bicarbonate (mEq/L) | 23–32 | 17.6 | 22.8 |
pH | 7.35–7.45 | 7.11 | |
Anion Gap (mEq/L) | 8–12 | 9 | |
AAN | <1:40 | 1:2560 | |
Anti-Ro (U/mL) | 0–16 | 145 | |
Anti-La (U/mL) | 0–16 | 89.88 | |
TSH (mIU/L) | 0.4–4 | 5.4 | 3 |
fT4 (ng/dL) | 0.76–1.39 | 1.25 | 1.25 |
T3 (nm/L) | 1.30–2,60 | 1.07 | 1.29 |
Anti-TPO | – | Negative | |
ATG | – | Negative | |
Urinalysis | |||
pH | 5–7.5 | 7.5 | 7 |
Gravity | 1.015–1.020 | 1.008 | |
Glucose (mg/dL) | – | 500 | 200 |
Proteins (mg/dL) | – | 150 | |
Pyrilinks-D (nMDPD/mM) | 3–7.4 | 14.04 | |
Calcium (mg/24 h) | 100–300 | 112 | |
Phosphorus (mg/24 h) | 400–1300 | 525.3 | |
Ophtalmological tests | |||
Schirmer (5 min) | 0 mm | ||
Tear break-up time | Unstable | ||
Fluorescein eye stain | Positive |